NCT02191319View on ClinicalTrials.gov

Observational Study With Antiretroviral Treated Patients Switching to Nevirapine Plus Two Nucleoside Reverse Transcriptase Inhibitor (NRTI) Regimens

CompletedOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

August 31, 2004

Conditions
HIV Infections
Interventions
DRUG

Viramune®

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02191319 - Observational Study With Antiretroviral Treated Patients Switching to Nevirapine Plus Two Nucleoside Reverse Transcriptase Inhibitor (NRTI) Regimens | Biotech Hunter | Biotech Hunter